Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid

scientific article published in June 2010

Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/ART.27414
P698PubMed publication ID20178128
P5875ResearchGate publication ID41533388

P50authorLeendert A TrouwQ40406948
Rene E ToesQ42494390
Hans Ulrich SchererQ42663741
Manfred WuhrerQ45905459
Gerd-Rüdiger BurmesterQ47261275
Andreea Ioan-FacsinayQ47657307
Diane van der WoudeQ55314080
Tom HuizingaQ77086497
Hanane el BannoudiQ114563694
P2093author name stringJun Wang
Thomas Häupl
André M Deelder
P2860cites workLack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicityQ30835165
Glycoform-dependent conformational alteration of the Fc region of human immunoglobulin G1 as revealed by NMR spectroscopy.Q38317804
Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis.Q42169367
P433issue6
P921main subjectantibodyQ79460
P304page(s)1620-1629
P577publication date2010-06-01
P1433published inArthritis & RheumatologyQ4797636
P1476titleGlycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid
P478volume62

Reverse relations

cites work (P2860)
Q38634916A Comprehensive Review of Immunoreceptor Regulation of Osteoclasts
Q41701035A method to identify trace sulfated IgG N-glycans as biomarkers for rheumatoid arthritis.
Q40513802A specific anti-citrullinated protein antibody profile identifies a group of rheumatoid arthritis patients with a toll-like receptor 4-mediated disease
Q35939105Acute phase inflammation is characterized by rapid changes in plasma/peritoneal fluid N-glycosylation in mice
Q39146323Affinity purified anti-citrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint
Q48138068Altered glycan accessibility on native immunoglobulin G complexes in early rheumatoid arthritis and its changes during therapy.
Q36125875Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy
Q58234756Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis
Q37311301Anti-rhesus D prophylaxis in pregnant women is based on sialylated IgG antibodies
Q64122268Antibody-dependent and -independent mechanisms of inflammatory arthritis
Q41762205Autoantibodies targeting tumor-associated antigens in metastatic cancer: Sialylated IgGs as candidate anti-inflammatory antibodies
Q37693939Autoantibodies to posttranslational modifications in rheumatoid arthritis
Q38177181Autoantibody-mediated bone loss
Q37492376Autoimmunity to citrullinated proteins and the initiation of rheumatoid arthritis
Q39361224Cellular and molecular pathways of structural damage in rheumatoid arthritis
Q35878770Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination
Q36577396Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial
Q58572572Comparative Glycomics of Immunoglobulin A and G From Saliva and Plasma Reveals Biomarker Potential
Q55050150Complement in the Initiation and Evolution of Rheumatoid Arthritis.
Q33420853Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity
Q57676590Coupling porous sheathless interface MS with transient-ITP in neutral capillaries for improved sensitivity in glycopeptide analysis
Q50210105Defining the proteomic landscape of rheumatoid arthritis: progress and prospective clinical applications
Q47804590Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?
Q34568233Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages
Q34994340Fc-glycosylation of IgG1 is modulated by B-cell stimuli
Q38615357Fcγ receptor pathways during active and passive immunization
Q38388421Fingerprinting of anti-citrullinated protein antibodies (ACPA): specificity, isotypes and subclasses
Q42069958Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis
Q39295277Genetic risk scores and number of autoantibodies in patients with rheumatoid arthritis
Q26782025Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review
Q35003989Glycomic signatures on serum IgGs for prediction of postvaccination response
Q36742404Glycoproteomic analysis of antibodies
Q35311994Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss
Q92106772How Autoantibodies Regulate Osteoclast Induced Bone Loss in Rheumatoid Arthritis
Q36245665Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis
Q92027568IgE Glycosylation in Health and Disease
Q38631840IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis.
Q28545233IgG antibodies to cyclic citrullinated peptides exhibit profiles specific in terms of IgG subclasses, Fc-glycans and a fab-Peptide sequence
Q40108236IgG subclass and vaccination stimulus determine changes in antigen specific antibody glycosylation in mice.
Q43420843IgM rheumatoid factor amplifies the inflammatory response of macrophages induced by the rheumatoid arthritis-specific immune complexes containing anticitrullinated protein antibodies.
Q88650321Immunological responses to influenza vaccination: lessons for improving vaccine efficacy
Q34604615Insights from populations at risk for the future development of classified rheumatoid arthritis
Q36959840Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway.
Q38787980Label-free detection of immune complexes with myeloid cells.
Q45924953Low-avidity anticitrullinated protein antibodies (ACPA) are associated with a higher rate of joint destruction in rheumatoid arthritis.
Q36157114Microscale purification of antigen-specific antibodies
Q51740730Modulation of inflammatory arthritis by gut microbiota through mucosal inflammation and autoantibody generation.
Q36195303Multiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation
Q50497045Nanoscale reversed-phase liquid chromatography-mass spectrometry of permethylated N-glycans.
Q52608527Novel Concepts of Altered Immunoglobulin G Galactosylation in Autoimmune Diseases.
Q60301434Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies
Q35873009Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid
Q91844287Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential
Q26752274Recent Advances in Clinical Glycoproteomics of Immunoglobulins (Igs)
Q38957490Regulation of antibody effector functions through IgG Fc N-glycosylation
Q39251627Regulation of autoantibody activity by the IL-23-TH17 axis determines the onset of autoimmune disease
Q47700104Rheumatoid factors do not preferentially bind to ACPA-IgG or IgG with altered galactosylation.
Q57253408Role of sialylation in the anti-inflammatory activity of intravenous immunoglobulin - F(ab')₂ versus Fc sialylation
Q55347406Sialylated Autoantigen-Reactive IgG Antibodies Attenuate Disease Development in Autoimmune Mouse Models of Lupus Nephritis and Rheumatoid Arthritis.
Q36768842Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis.
Q36221190Structural Analysis of Variable Domain Glycosylation of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Reveals the Presence of Highly Sialylated Glycans
Q38239288Sweet and sour: the role of glycosylation for the anti-inflammatory activity of immunoglobulin G.
Q38851112Sweet but dangerous - the role of immunoglobulin G glycosylation in autoimmunity and inflammation.
Q37123859T cell-independent B cell activation induces immunosuppressive sialylated IgG antibodies.
Q58746430Tertiary Lymphoid Structures: Autoimmunity Goes Local
Q50129712The B cell response to citrullinated antigens in the development of rheumatoid arthritis.
Q60047547The Clinical Value of Autoantibodies in Rheumatoid Arthritis
Q47331159The Role of Autoantibodies in Bone Metabolism and Bone Loss
Q38117686The carbohydrate switch between pathogenic and immunosuppressive antigen-specific antibodies
Q38161557The case for measuring antibodies to specific citrullinated antigens.
Q37980340The influence of ACPA status and characteristics on the course of RA.
Q38206946The pathogenic potential of autoreactive antibodies in rheumatoid arthritis.
Q26862195The perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejection
Q50308665The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis
Q38815526The role of autoantibodies in the pathophysiology of rheumatoid arthritis
Q37995919The role of sialic acid as a modulator of the anti-inflammatory activity of IgG.
Q61452098The roles of anti-citrullinated protein antibodies in the immunopathogenesis of rheumatoid arthritis
Q38232105Type I and type II Fc receptors regulate innate and adaptive immunity
Q52728264Variable domain N-linked glycosylation and negative surface charge are key features of monoclonal ACPA: Implications for B-cell selection.
Q53057615[Association between bone catabolism and anti-citrullinated protein antibodies in rheumatoid arthritis].
Q85397964[Glycosylation-dependent effector function of IgG antibodies]

Search more.